Health and Healthcare Systems

COVID-19: What you need to know about the coronavirus pandemic on 10 June

A woman wearing a protective face mask sits at a shopping mall amid the coronavirus disease (COVID-19) outbreak in Jakarta, Indonesia, June 10, 2021. REUTERS/Ajeng Dinar Ulfiana - RC2IXN9TB7XU

Mask wearing has become the norm across the globe. Image: REUTERS/Ajeng Dinar Ulfiana

Joe Myers
Writer, Forum Stories
  • This daily round-up brings you a selection of the latest news and updates on the COVID-19 coronavirus pandemic, as well as tips and tools to help you stay informed and protected.
  • Top stories: Warning over virus spread in the Americas; Scottish study underscores rarity of complications from AstraZeneca vaccine; India reports highest single-day COVID-19 death toll.
Have you read?

1. How COVID-19 is affecting the globe

Confirmed cases of COVID-19 have passed 174.4 million globally, according to Johns Hopkins University. The number of confirmed deaths stands at more than 3.75 million. More than 2.22 billion vaccination doses have been administered globally, according to Our World in Data.

India has recorded the highest single-day death toll from COVID-19 in the world, at 6,148. The United States had previously recorded 5,444 on 12 February.

Two Australian states are rushing to trace contacts after an infected woman and her husband travelled from Victoria through New South Wales and into Queensland - visiting dozens of sites en route.

Canada has announced it's prepared to relax quarantine protocols for fully vaccinated citizens returning home starting in early July.

US President Joe Biden and British Prime Minister Boris Johnson are expected to work to open up travel between the two countries as soon as possible, the British government said in a statement.

South Korea is considering vaccinating workers at key businesses - including chip and electronic firms - the government has said. It comes amid global efforts to boost supply of scarce computer chips.

The US government has agreed to buy 1.7 million courses of Merck & Co's experimental COVID-19 treatment, if it is proven to work in an ongoing trial and approved by regulators, the company said yesterday.

Stricter COVID-19 rules will remain in place in Lisbon next Monday, as restrictions relax in most of Portugal, as a result of concern about rising COVID-19 cases.

The Delta coronavirus variant of concern is believed to be 60% more transmissible than the Alpha variant, a prominent UK epidemiologist said yesterday.

Discover

How is the World Economic Forum helping to identify new technologies to fight COVID-19?

2. If COVID-19 trends continue, it could be years before virus is controlled - PAHO

The Pan American Health Organization (PAHO) has warned that if the spread of COVID-19 continues at current rates, it will be years before it is controlled in the Americas.

"If current trends continue, the health, social and economic disparities in our region will grow even larger, and it will be years before we control this virus in the Americas," PAHO Director Carissa Etienne told a weekly news conference.

The organization called for more vaccine donations, with just 10% of the populations of Latin America and the Caribbean fully vaccinated. "Vaccine donations are essential in the short-term," Etienne said.

COVID-19 vaccine doses administered by continent.
COVID-19 vaccine doses administered by continent. Image: Our World in Data

3. Scottish study underscores rarity of complications from AstraZeneca jab

A Scottish study has underscored the rarity of potential complications associated with the AstraZeneca COVID-19 vaccine.

The research, published in the journal Nature Medicine, found only an association with a largely harmless bleeding condition and no link to brain clots.

The researchers tracked the health of 5.4 million people in Scotland, found that one additional case of idiopathic thrombocytopenic purpura (ITP) per 100,000 people occurred after the first injection of the AstraZeneca vaccine.

The study found no association with venous clotting in the brain - known as CVST. However, the study's lead University of Edinburgh Professor Aziz Sheikh cautioned the sample might have been too small to allow for any conclusions given the rarity of CVST.

"The overall message is just the rarity of these outcomes," said Aziz. "This is reassuring data, and we would very strongly encourage people, when they receive the invitation to get vaccinated, to go ahead."

Loading...
Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Stay up to date:

Global Health

Share:
The Big Picture
Explore and monitor how Global Health is affecting economies, industries and global issues
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.

Subscribe today

These collaborations are already tackling climate-driven health risks but more can be done to find solutions

Fernando J. Gómez and Elia Tziambazis

December 20, 2024

Investing in children’s well-being: The urgent need for expanded mental health and psychosocial support funding

About us

Engage with us

  • Sign in
  • Partner with us
  • Become a member
  • Sign up for our press releases
  • Subscribe to our newsletters
  • Contact us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2024 World Economic Forum